1-5 of 5
Umberto Arena
Close
Sort by
Journal Articles

Long Term Follow up of a Phase 2 Study of Ruxolitinib in Patients with Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasm

Lisa Pieri, MD PhD, Chiara Paoli, BS, Umberto Arena, MD, Fabio Marra, MD, Fabio Mori, MD, Mery Zucchini, MD, Stefano Colagrande, MD, Alessandro Castellani, MD, Arianna Masciulli, PhD MSc, Vittorio Rosti, MD, Valerio De Stefano, MD, Silvia Betti, MD, Guido Finazzi, MD, Maria Luisa Ferrari, BSc, Elisa Rumi, MD, Marco Ruggeri, MD, Ilaria Nichele, MD, Paola Guglielmelli, MD PhD, Rajmonda Fjerza, MD, Carmela Mannarelli, MSc, Tiziana Fanelli, MSc, Lucia Merli, BSN, Margherita Massa, PhD, Giuseppe Cimino, MD, Alessandro Rambaldi, MD, Giovanni Barosi, MD, Mario Cazzola, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD
Journal: Blood
Blood (2015) 126 (23): 2803.
https://doi.org/10.1182/blood.V126.23.2803.2803
Published: 2015
Journal Articles

A Phase 2 Study of Ruxolitinib in Patients with Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasm: A Study from the AGIMM Group

Lisa Pieri, MDPhD, Chiara Paoli, MSc, Umberto Arena, MD, Fabio Marra, MD, Alessandro Castellani, MD, Stefano Colagrande, MD, Fabio Mori, MD, Arianna Masciulli, MSc, PhD, Silvia Betti, MD, Vittorio Rosti, MD, Ilaria Nichele, MD, Guido Finazzi, MD, Maria Luisa Ferrari, MD, Elisa Rumi, MD, Paola Guglielmelli, MD PhD, Rajmonda Fjerza, MD, Carmela Mannarelli, MSc, Tiziana Fanelli, MSc, Alberto Bosi, MD, Giuseppe Cimino, MD, Francesco Passamonti, MD, Valerio De Stefano, MD, Marco Ruggeri, MD, Mario Cazzola, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro Maria Vannucchi, MD
Journal: Blood
Blood (2014) 124 (21): 3192.
https://doi.org/10.1182/blood.V124.21.3192.3192
Published: 2014
Journal Articles

A Phase 2 Study Of Ruxolitinib In Patients With Splanchnic Vein Thrombosis Associated With Myeloproliferative Neoplasm. Preliminary Results

Lisa Pieri, MD, PhD, Chiara Paoli, BiSci, Paola Guglielmelli, PhD MD, Rajmonda Fjerza, MD, Umberto Arena, MD, Fabio Marra, MD, Stefano Colagrande, MD, Fabio Mori, MD, Roberto Marchioli, MD, Raffaella Pioggiarella, PharmD, Marco Ruggeri, MD, Ilaria Nichele, MD, Guido Finazzi, MD, Maria Luisa Ferrari, MD, Vittorio Rosti, MD, Valerio De Stefano, MD, Elisa Rumi, MD, Carmela Mannarelli, BiSci, Tiziana Fanelli, BiSci, Alberto Bosi, Alessandro Rambaldi, MD, Giovanni Barosi, MD, Mario Cazzola, MD, Tiziano Barbui, MD, Alessandro M Vannucchi, MD
Journal: Blood
Blood (2013) 122 (21): 1583.
https://doi.org/10.1182/blood.V122.21.1583.1583
Published: 2013
Journal Articles

Safety and efficacy of rituximab in patients with hepatitis C virus–related mixed cryoglobulinemia and severe liver disease

Clinical Trials & Observations
Antonio Petrarca, Luigi Rigacci, Patrizio Caini, Stefano Colagrande, Paolo Romagnoli, Francesco Vizzutti, Umberto Arena, Carlo Giannini, Monica Monti, Paolo Montalto, Marco Matucci-Cerinic, Alberto Bosi, Giacomo Laffi, Anna Linda Zignego
Journal: Blood
Blood (2010) 116 (3): 335–342.
https://doi.org/10.1182/blood-2009-11-253948
Published: 2010
Journal Articles

Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia

Carlo Giannini, Antonio Petrarca, Monica Monti, Umberto Arena, Patrizio Caini, Vera Solazzo, Laura Gragnani, Stefano Milani, Giacomo Laffi, Anna Linda Zignego
Journal: Blood
Blood (2008) 111 (5): 2943–2945.
https://doi.org/10.1182/blood-2007-09-112490
Published: 2008